International Journal of Clinical Pharmacy

, Volume 37, Issue 2, pp 395–402 | Cite as

A drop-in clinic for patients with poorly-controlled diabetes: a community pharmacy feasibility study

  • Michael J. TwiggEmail author
  • Debi Bhattacharya
  • James A. Desborough
  • David Wright
Research Article


Background Preparatory work suggests that there may be a role for the pharmacist in managing sub-optimal medication adherence and dose titration of prescribed medicines in patients with type 2 diabetes. Patients have reported that they are receptive towards pharmacists becoming involved in their care providing that this is integrated into the care received from their medical practice. Objective To determine whether a community pharmacy diabetes drop-in clinic is feasible and acceptable to patients with poorly controlled type 2 diabetes. Setting Five community pharmacies in Norfolk, UK. Method Poorly controlled patients, as defined by a national general practitioner incentive scheme, were invited to participate in the study by a letter posted by their medical practice. One 4-h, pharmacist clinic, where participants were able to “drop-in”, was conducted in five pharmacies every week for 4–6 weeks. Questionnaires before and after the consultation were used to determine the clinic’s effect on satisfaction with, and beliefs about, medicines and adherence along with participant satisfaction. Pharmacists had the opportunity to provide feedback via “debrief” interviews. Main outcome measure As a feasibility study, a combination of outcomes were explored including information satisfaction and adherence. Results Thirty-three (9.6 %) of the 342 paients with type 2 diabetes posted letters were recruited from four pharmacies. Follow-up questionnaire completion rate was 88 %. The clinic demonstrated little change in the parameters measured over 3 months. All of the participants rated their general impression of the service as good or very good and all would be happy to recommend the service to others with diabetes. Sixteen participants (59 %) stated that it would make them more likely to consult their pharmacist in the future. Pharmacists enjoyed providing the service as it allowed them to interact more formally, and for longer, with patients. Conclusion This research has demonstrated that a community pharmacy drop-in clinic is feasible and likely to be acceptable to both patients and pharmacists; however, cost effectiveness of such a service should be explored in future studies.


Adherence Community pharmacy Drop-in clinic Medicine use review MUR Type 2 diabetes United Kingdom 



The research team would like to thank the medical practices and pharmacies for volunteering to participate in this project. The pharmacies and medical practices were not paid for participating in the study.


This work was funded jointly by Numark Pharmacy Ltd and the UEA.

Conflicts of interest



  1. 1.
    Department of Health. Choosing health through pharmacy—a programme for pharmaceutical public health 2005–2015. London: The Stationery Office; 2005.Google Scholar
  2. 2.
    The Health and Social Care Information Centre & The Yorkshire and Humber Public Health Observatory, Prescribing for diabetes in England—An update: 2002–2008. 2009.Google Scholar
  3. 3.
    NICE. Type 2 diabetes: The management of type 2 diabetes (CG87). London: National Institute of Health and Clinical Excellence; 2009.Google Scholar
  4. 4.
    Health & Social Care Information Centre. National Diabetes Audit 2011–2012 Report 1: Care Processes and Treatment Targets. London: Health & Social Care Information Centre; 2013.Google Scholar
  5. 5.
    Twigg MJ, et al. An audit of prescribing for type 2 diabetes in primary care: optimising the role of the community pharmacist in the primary healthcare team. Prim Health Care Res Dev. 2013;14(03):315–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Department of Health. Pharmacy in England: building on strengths—delivering the future. London: The Stationery Office; 2008.Google Scholar
  7. 7.
    Department of Health. A vision for pharmacy in the new NHS. London: The Stationery Office; 2003.Google Scholar
  8. 8.
    Correr CJ, et al. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Fornos J, et al. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28(2):65–72.CrossRefPubMedGoogle Scholar
  10. 10.
    Krass I, et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Krass I, et al. Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabet Med. 2011;28(8):987–93.CrossRefPubMedGoogle Scholar
  12. 12.
    Mehuys E, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Therapeut. 2011;36(5):602–13.CrossRefGoogle Scholar
  13. 13.
    Oyetayo O, et al. The Hispanic Diabetes Management Program: impact of community pharmacists on clinical outcomes. JAPhA. 2011;51(5):623–6.PubMedGoogle Scholar
  14. 14.
    Taylor SJ, et al. A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. Int J Pharm Pract. 2005;13:33–44.CrossRefGoogle Scholar
  15. 15.
    Wermeille J, et al. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmaicst into the diabetes team—a pilot study. Pharm World Sci. 2004;26:18–25.CrossRefPubMedGoogle Scholar
  16. 16.
    Ali M, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012;29(9):e326–33.CrossRefPubMedGoogle Scholar
  17. 17.
    Twigg M, et al. The current and future roles of community pharmacists: views and experiences of patients with type 2 diabetes. Res Soc Admin Pharm. 2012;9(6):777–89.CrossRefGoogle Scholar
  18. 18.
    Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.CrossRefGoogle Scholar
  19. 19.
    Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10(3):135–40.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Morisky D, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.CrossRefPubMedGoogle Scholar
  21. 21.
    Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosomat Res. 1999;47(6):555–67.CrossRefGoogle Scholar
  22. 22.
    Graneheim U, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105.CrossRefPubMedGoogle Scholar
  23. 23.
    Matsuyama JR, Mason BJ, Jue SG. Pharmacists’ interventions using an electronic medication-event monitoring device’s adherence data versus pill counts. Ann Pharmacother. 1993;27(7–8):851–5.PubMedGoogle Scholar
  24. 24.
    Carr-Hill R, et al. Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy. 1998;3(4):207–13.PubMedGoogle Scholar
  25. 25.
    Curtis L. Unit Costs of Health and Social Care 2012, Personal Social Services Research Unit and University of Kent, Editors. 2012.Google Scholar
  26. 26.
    Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open. 2013;3(8):e002749.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Michael J. Twigg
    • 1
    Email author
  • Debi Bhattacharya
    • 1
  • James A. Desborough
    • 1
  • David Wright
    • 1
  1. 1.School of PharmacyUniversity of East AngliaNorwichUK

Personalised recommendations